(Q53051177)

English

Long-term efficacy of Serenoa repens treatment in patients with mild and moderate symptomatic benign prostatic hyperplasia.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/21304222

Long-term efficacy of Serenoa repens treatment in patients with mild and moderate symptomatic benign prostatic hyperplasia. (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/21304222

object named as

Serenoa repens

1 reference

based on heuristic

inferred from title

author name string

Ioanel Sinescu

1

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/21304222

Petrisor Geavlete

2

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/21304222

Razvan Multescu

3

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/21304222

Constantin Gangu

4

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/21304222

Florin Miclea

5

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/21304222

Ioan Coman

6

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/21304222

Ioan Ioiart

7

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/21304222

Valentin Ambert

8

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/21304222

Traian Constantin

9

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/21304222

Bogdan Petrut

10

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/21304222

Bogdan Feciche

11

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/21304222

publication date

8 February 2011

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/21304222

Urologia Internationalis

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/21304222

86

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/21304222

3

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/21304222

284-289

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/21304222

Evaluation of the clinical benefit of permixon and tamsulosin in severe BPH patients-PERMAL study subset analysis

1 reference

https://api.crossref.org/works/10.1159%2F000322645

21 January 2018

Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients

1 reference

https://api.crossref.org/works/10.1159%2F000322645

21 January 2018

Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1159%2F000322645

21 January 2018

Long-term clinical and biologic effects of the lipidosterolic extract of Serenoa repens in patients with symptomatic benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1159%2F000322645

21 January 2018

Not all brands are created equal: a comparison of selected components of different brands of Serenoa repens extract

1 reference

https://api.crossref.org/works/10.1159%2F000322645

21 January 2018

Serenoa repens (saw palmetto): a systematic review of adverse events

1 reference

https://api.crossref.org/works/10.1159%2F000322645

21 January 2018

A detailed safety assessment of a saw palmetto extract

1 reference

https://api.crossref.org/works/10.1159%2F000322645

21 January 2018

Impact of medical treatments for benign prostatic hyperplasia on sexual function

1 reference

https://api.crossref.org/works/10.1159%2F000322645

21 January 2018

Evaluation of male sexual function in patients with Lower Urinary Tract Symptoms (LUTS) associated with Benign Prostatic Hyperplasia (BPH) treated with a phytotherapeutic agent (Permixon), Tamsulosin or Finasteride

1 reference

https://api.crossref.org/works/10.1159%2F000322645

21 January 2018

Saw palmetto for benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1159%2F000322645

21 January 2018

A prospective study of the efficacy of Serenoa repens, tamsulosin, and Serenoa repens plus tamsulosin treatment for patients with benign prostate hyperplasia.

1 reference

https://api.crossref.org/works/10.1159%2F000322645

21 January 2018

Finasteride significantly reduces acute urinary retention and need for surgery in patients with symptomatic benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1159%2F000322645

21 January 2018

Identifiers

10.1159/000322645

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/21304222

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/21304222

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53051177&oldid=1610913026"